Trial Details

COMPLETED
Basic Information
Clinical ID c2972
Identifier NCT02712866
Trial Title Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Disease Patients.
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Parc de Salut Mar
City Hospital del Mar
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2017-01
Primary Completion Date 2019-02
Completion Date 2019-02